<- Go Home
PetVivo Holdings, Inc.
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company’s pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.
Market Cap
$11.0M
Volume
40.7K
Cash and Equivalents
$126.2K
EBITDA
-$8.9M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$739.5K
Profit Margin
76.34%
52 Week High
$1.50
52 Week Low
$0.29
Dividend
N/A
Price / Book Value
26.09
Price / Earnings
-1.07
Price / Tangible Book Value
27.91
Enterprise Value
$12.5M
Enterprise Value / EBITDA
-1.41
Operating Income
-$9.0M
Return on Equity
1233.77%
Return on Assets
-155.22
Cash and Short Term Investments
$126.2K
Debt
$1.6M
Equity
$409.2K
Revenue
$968.6K
Unlevered FCF
-$2.8M
Sector
Health Care Equipment and Supplies
Category
N/A